Meeker David P
SEC insider (Form 3/4/5 filer). CIK 0001385155. President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM) and 3 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in BOSTON, MA.
Companies Meeker David P has filed insider reports for
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director, Officer, President and CEO
- Kardigan, Inc. (KARD): Director
- Trevi Therapeutics, Inc. (TRVI): Director
- Pharvaris N.V. (PHVS): Director
Meeker David P
CIK: 0001385155
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect2.3K shares at avg. $105.19$242K - Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect1.8K shares at avg. $104.55$190K - Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
ExerciseDirect50K shares at avg. $6.05$303K - Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect6.4K shares at avg. $101.75$655K - Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect30.7K shares at avg. $102.35$3.1M - Sep 14, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
SaleDirect8.7K shares at avg. $103.43$900K - Jun 17, 2026KARD
Kardigan, Inc.
AwardDirect20.7K shares- - Jun 3, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectNonstatutory Stock Option (right to buy)
35K shares- - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
71.9K shares- - Feb 11, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
AwardDirectStock Options (Right to Buy)
107.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 |  RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 2,300 | $105.19 | $241,937 | Direct |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 1,817 | $104.55 | $189,965 | Direct |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Exercise | 50,000 | $6.05 | $302,500 | Direct |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 6,439 | $101.75 | $655,145 | Direct |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 30,746 | $102.35 | $3,146,761 | Direct |
| Sep 14, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Sale | 8,698 | $103.43 | $899,634 | Direct |
| Jun 17, 2026 |  KARD Kardigan, Inc. | Award | 20,706 | - | $0 | Direct |
| Jun 3, 2026 |  TRVI Trevi Therapeutics, Inc. | Award Nonstatutory Stock Option (right to buy) | 35,000 | - | - | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Restricted Stock Units | 71,900 | - | - | Direct |
| Feb 11, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Award Stock Options (Right to Buy) | 107,850 | - | - | Direct |
1-10 of 22 transactions